Status:
ACTIVE_NOT_RECRUITING
BRCA Founder OutReach (BFOR) Study
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
Dana-Farber Cancer Institute
University of Pennsylvania
Conditions:
BRCA1 Mutation
BRCA2 Mutation
Eligibility:
All Genders
25+ years
Brief Summary
The purpose of this study is to learn how to provide BRCA gene testing to a larger number of people as well as to make testing part of a person's regular medical care.
Eligibility Criteria
Inclusion
- Self-reported age ≥ 25
- Self identify as having at least one of their four grandparents as Ashkenazi Jewish
- Has medical insurance
- Able to understand and read the English-language
- Zip code falls within the catchment areas of the phase of the study (e.g. New York City, Boston, Philadelphia, Los Angeles) accessible to a BFOR designated provider
Exclusion
- Under age 25
- No Ashkenazi Jewish ancestry
- Does not have insurance
- Has previously had medical BRCA testing ordered by a health care provider
Key Trial Info
Start Date :
November 10 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 10 2026
Estimated Enrollment :
5412 Patients enrolled
Trial Details
Trial ID
NCT03351803
Start Date
November 10 2017
End Date
May 10 2026
Last Update
June 3 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Los Angeles
Los Angeles, California, United States, 90095
2
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115
3
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
4
Memorial Sloan - Kettering Cancer Center
New York, New York, United States, 10021